Tumor Necrosis Factor-α Induced Protein 8 Polymorphism and Risk of Non-Hodgkin’s Lymphoma in a Chinese Population: A Case-Control Study

• Yan Zhang,

  Affiliations Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China

  ⨯
• Meng-Yun Wang,

  Affiliations Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China, Cancer Research Laboratory, Fudan University Shanghai Cancer Center, Shanghai, China

  ⨯
• Jing He,

  Affiliations Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China, Cancer Research Laboratory, Fudan University Shanghai Cancer Center, Shanghai, China

  ⨯
• Jiu-Cun Wang,

  Affiliations Ministry of Education Key Laboratory of Contemporary Anthropology and State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai, China, Fudan-Taizhou Institute of Health Sciences, Taizhou, Jiangsu, China

  ⨯
• Ya-Jun Yang,

  Affiliations Ministry of Education Key Laboratory of Contemporary Anthropology and State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai, China, Fudan-Taizhou Institute of Health Sciences, Taizhou, Jiangsu, China

  ⨯
• Li Jin,

  Affiliations Ministry of Education Key Laboratory of Contemporary Anthropology and State Key Laboratory of Genetic Engineering, School of Life Sciences, Fudan University, Shanghai, China, Fudan-Taizhou Institute of Health Sciences, Taizhou, Jiangsu, China

  ⨯
• Zhi-Yu Chen,

  Affiliations Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China

  ⨯
• Xue-Jun Ma,

  Affiliations Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China, Department of Radiation Oncology, Fudan University Shanghai Cancer Center, Shanghai, China

  ⨯
• Meng-Hong Sun,

  Affiliations Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China, Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China

  ⨯
• Kai-Qin Xia,

  Affiliations Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China, Cancer Research Laboratory, Fudan University Shanghai Cancer Center, Shanghai, China, Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China

  ⨯
• Xiao-Nan Hong ,

  * E-mail: xyzhou100@yahoo.com (XYZ); xnhong@126.com (XNH)

  Affiliations Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China

  ⨯
• Qing-Yi Wei,

  Affiliations Cancer Research Laboratory, Fudan University Shanghai Cancer Center, Shanghai, China, Department of Epidemiology, the University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• Xiao-Yan Zhou

  * E-mail: xyzhou100@yahoo.com (XYZ); xnhong@126.com (XNH)

  Affiliations Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China, Cancer Research Laboratory, Fudan University Shanghai Cancer Center, Shanghai, China, Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China

  ⨯